As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published o ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The 38-year-old information technology worker from New Mexico had a prescription ... Now that millions of people have used the drugs, several obesity experts told The Associated Press that ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

Dr. Bisher Mustafa of the Marshall Health Obesity Clinic in Huntington said there's a certain irony to waiting "until people have diabetes to start the medication." "The idea is to try to prevent ...